VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SYRESpyre Therapeutics, Inc.
$87.89$30.4B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksSYREPrice History

SYRE logoSpyre Therapeutics, Inc. (SYRE) Stock Price History

Historical prices from 2016 to 2026

$87.89-0.78  (-0.88%)close Jun 26
Returns
1M
+19.4%
3M
+85.0%
YTD
+187.4%
1Y
+448.6%
3Y
+110.1%
5Y
-13.9%
ATH$318.75Apr 2016-72.4%
ATL$2.65Jun 2023pre-split
Avg Vol (50D)1.1M/ day
52-Week Range$14.00 — $102.06
LowCurrent: $87.89High

Loading 10-year price history...

SYRE Historical Performance

1 YearTotal Return
+459.1%
Price: +448.6%
3 YearsTotal Return
+808.9%
CAGR: +108.7%
Price: +827.1%
5 YearsTotal Return
-51.1%
CAGR: -13.3%
Price: -52.6%
YTD
+187.4%

SYRE Annual Returns

Year-by-year price performance · 2016–2026

Best+104.4%2023
Worst-90.6%2022
Up years7/11
2016-55.5%
2017+18.4%
2018+39.2%
2019-5.0%
2020+1.5%
2021-44.5%
2022-90.6%
2023+104.4%
2024+8.8%
2025+37.4%
2026+40.6%
2016 annual price return
-55.5%
2017 annual price return
+18.4%
2018 annual price return
+39.2%
2019 annual price return
-5.0%
2020 annual price return
+1.5%
2021 annual price return
-44.5%
2022 annual price return
-90.6%
2023 annual price return
+104.4%
2024 annual price return
+8.8%
2025 annual price return
+37.4%
2026 annual price return
+40.6%
LessMore
Alpha vs S&P 500
1Y+438.3%
3Y+94.0%
5Y-21.4%

Price returns only.

Download Historical Data

2,571 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

SYRE Stock Price Trajectory (2016–2026)

As of June 28, 2026, Spyre Therapeutics, Inc. (SYRE) trades at $87.89, representing a +448.6% return over the past year. The stock has delivered a -51.1% total return over five years (-13.9% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $318.75 on April 8, 2016. From this peak, SYRE has corrected -72.4%, currently trading 106% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers ARRY (+9.5% 1Y), PRTA (+62.1% 1Y), and TRMB (-32.4% 1Y), SYRE has underperformed the peer group average. Compare SYRE vs ARRY →

SYRE Historical Price Data · from 2016

Rows 1–50 of 2,571
Date Open High Low Close Volume Change %
2026-06-2688.4489.8885.9787.890-0.88%
2026-06-2586.4689.6784.9688.671.86M+2.91%
2026-06-2483.2288.0581.6586.164.03M-11.22%
2026-06-2397.92102.0695.3197.052.54M-3.26%
2026-06-2295.00101.7095.00100.322.77M+13.56%
2026-06-1889.5590.9986.2288.341.97M+0.97%
2026-06-1784.7388.0383.1787.491.50M+4.90%
2026-06-1683.5484.9281.7083.401.04M-0.22%
2026-06-1581.5784.6980.7983.58203K+3.45%
2026-06-1281.0984.4380.7180.79787K+0.02%
2026-06-1175.7481.6275.3580.771.25M+7.58%
2026-06-1075.9179.5274.7975.08954K-1.78%
2026-06-0972.9777.1170.8976.441.53M+6.17%
2026-06-0875.5376.3171.1172.00946K-2.24%
2026-06-0577.9278.9073.0673.65946K-6.08%
2026-06-0473.5779.5473.3078.42951K+6.91%
2026-06-0370.0576.1169.8173.351.58M+6.06%
2026-06-0269.9970.5068.5669.16795K-1.96%
2026-06-0173.0573.0568.9770.54895K-4.03%
2026-05-2972.4274.0071.5273.50879K+1.93%
2026-05-2872.0173.3371.0872.11421K-0.55%
2026-05-2773.9374.3572.2472.51550K-1.49%
2026-05-2674.8775.8172.1173.61470K-0.59%
2026-05-2275.3475.6374.0074.05550K-0.36%
2026-05-2170.8974.4370.5574.32680K+3.44%
2026-05-2068.6472.4767.8871.851.04M+7.85%
2026-05-1967.6069.5464.7566.621.35M-4.94%
2026-05-1875.0975.6069.0170.081.06M-6.51%
2026-05-1577.0877.0872.5474.961.32M-0.91%
2026-05-1477.7677.7674.4975.65369K-0.86%
2026-05-1375.5578.0073.4876.31752K+1.69%
2026-05-1275.8776.9473.2275.04998K-1.82%
2026-05-1175.1578.8074.3976.431.31M+1.85%
2026-05-0873.1075.9172.4075.05833K+2.66%
2026-05-0773.9974.5071.1373.10915K+0.14%
2026-05-0672.0173.4570.1173.00664K+2.90%
2026-05-0570.6473.2270.2170.941.67M+2.62%
2026-05-0468.2671.6767.1869.13698K-0.42%
2026-05-0174.0976.0069.2369.421.43M-6.76%
2026-04-3072.3375.0072.0874.45918K+3.56%
2026-04-2967.9973.6167.5071.891.69M+4.75%
2026-04-2872.2973.9568.2068.631.01M-4.55%
2026-04-2771.2572.3069.5371.90605K+3.20%
2026-04-2469.8370.2368.4369.67500K+0.62%
2026-04-2373.0273.7368.3369.24646K-5.15%
2026-04-2272.9674.3571.7173.001.02M+2.43%
2026-04-2173.3974.6169.9571.271.27M-2.89%
2026-04-2072.2074.6872.0373.39874K+0.52%
2026-04-1770.3274.6070.2173.011.85M+4.75%
2026-04-1668.9470.3066.8869.702.19M+1.03%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

SYRE — Frequently Asked Questions

Quick answers to the most common questions about buying SYRE stock.

How has SYRE stock performed recently?

SYRE returned +448.6% over the past year, beating its 5-year annualized CAGR of -13.9%. The stock trades above its 200-day moving average, confirming the uptrend.

What is SYRE's all-time high price?

Spyre Therapeutics, Inc. reached $318.75 on 2016-04-08. The 52-week high is $102.06. Current 1-year return of +448.6% places the stock closer to historical peaks.

Where can I download SYRE historical price data?

This page provides SYRE daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2016-2026, downloadable in CSV format.

430 data points · sampled from 2,571